Search for: "Momenta, Inc."
Results 21 - 40
of 54
Sorted by Relevance
|
Sort by Date
6 Aug 2012, 8:12 pm
Noonan -- In his dissent from the majority opinion in Momenta Pharmaceuticals, Inc. v. [read post]
11 Mar 2019, 7:08 pm
After a long wait, the Federal Circuit last month decided Momenta Pharms. v. [read post]
3 Oct 2016, 9:36 pm
Momenta Pharmaceuticals, Inc., thereby leaving intact the Federal Circuit's fractured precedent on the question of whether post-approval activities are properly within the scope of the Hatch-Waxman "safe harbor" (as set forth in 35 U.S.C. [read post]
7 Aug 2012, 11:45 pm
The Momenta v. [read post]
9 Feb 2018, 7:13 am
" Momenta Pharmaceuticals, Inc., et al v. [read post]
1 Dec 2021, 8:34 am
” Momenta, 915 F.3d at 770. [read post]
29 Aug 2017, 1:17 pm
Patent Docs has a post on the July 21 decision in MOMENTA PHARMACEUTICALS v. [read post]
3 Apr 2013, 4:45 am
But the recent split Federal Circuit panel decision in Momenta Pharmaceuticals, Inc. v. [read post]
11 Sep 2012, 5:30 am
But the recent split Federal Circuit panel decision in Momenta Pharmaceuticals, Inc. v. [read post]
3 Nov 2010, 7:00 am
Two years later, Momenta Pharmaceuticals Inc. and its partner Sandoz, part of Novartis AG, filed. [read post]
7 Aug 2012, 7:43 pm
Amphastar Pharmaceuticals, Inc. [read post]
30 Mar 2011, 6:17 am
. * * * [One] of the companies whose stock he allegedly traded was Momenta Pharmaceuticals Inc., a small biotechnology company from Cambridge, Mass., which was vying with two other companies to make a generic version of the blockbuster blood thinner Lovenox. [read post]
14 Apr 2014, 3:51 pm
The generic firms — Sandoz Inc., Momenta Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., and Natco Pharma Ltd. [read post]
3 Jun 2016, 6:40 am
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Exhaustion: Impression Products, Inc. v. [read post]
4 Jan 2013, 7:03 am
Momenta Pharmaceuticals, Inc. v. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
11 Mar 2019, 1:03 pm
Momenta Pharms., Inc., 2018 WL 6378457 (M.D. [read post]
27 Mar 2024, 10:56 am
The 2019 decision Amgen Inc. v. [read post]
18 Sep 2016, 6:03 pm
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Post Grant Admin: MCM v. [read post]
5 Sep 2016, 6:46 pm
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Post Grant Admin: MCM v. [read post]